Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas
- 1 March 1980
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 17 (3) , 474-476
- https://doi.org/10.1128/aac.17.3.474
Abstract
The activity of cefotaxime, either alone or combined with an aminoglycoside, was determined against 50 isolates of Pseudomonas aeruginosa, of which 50, 33, and 10 were resistant to gentamicin, tobramycin, and amikacin, respectively. Cefotaxime inhibited 34 isolates at a concentration of 16 microgram/ml and all isolates at 128 microgram/ml. The combinations of cefotaxime with gentamicin, tobramycin, and amikacin were synergistic against 30, 17, and 9 isolates, respectively, and no antagonism was observed with any combination. Synergism was obtained at clinically significant antibiotic concentrations for nine isolates with cefotaxime-gentamicin, five isolates with cefotaxime-tobramycin, and nine isolates with cefotaxime-amikacin.This publication has 9 references indexed in Scilit:
- In Vitro Activity of HR 756, a New Cephalosporin, Against Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 1979
- HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979
- Comparison of the In Vitro Activities of HR756 with Cephalothin, Cefoxitin, and CefamandoleAntimicrobial Agents and Chemotherapy, 1978
- Analysis of the Interactions Between Piperacillin, Ticarcillin, or Carbenicillin and Aminoglycoside AntibioticsAntimicrobial Agents and Chemotherapy, 1978
- CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDEThe Lancet, 1978
- Activity of HR 756 against Haemophilus influenzae, Barteroides fragilis and Gram-negative rodsJournal of Antimicrobial Chemotherapy, 1978
- In vitro activity of HR 756, a new cephalosporin compound.The Journal of Antibiotics, 1978
- Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-TobramycinAntimicrobial Agents and Chemotherapy, 1975